Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.
2.

Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055.

Kumari S, Harjai K, Chhibber S.

J Med Microbiol. 2011 Feb;60(Pt 2):205-10. doi: 10.1099/jmm.0.018580-0. Epub 2010 Oct 21.

PMID:
20965914
3.

Topical treatment of Klebsiella pneumoniae B5055 induced burn wound infection in mice using natural products.

Kumari S, Harjai K, Chhibber S.

J Infect Dev Ctries. 2010 Jun 30;4(6):367-77.

4.

Efficacy of bacteriophage treatment in murine burn wound infection induced by klebsiella pneumoniae.

Kumari S, Harjai K, Chhibber S.

J Microbiol Biotechnol. 2009 Jun;19(6):622-8.

5.

Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice.

Chhibber S, Kaur S, Kumari S.

J Med Microbiol. 2008 Dec;57(Pt 12):1508-13. doi: 10.1099/jmm.0.2008/002873-0.

PMID:
19018021
6.

Protection with bacteriophage KØ1 against fatal Klebsiella pneumoniae-induced burn wound infection in mice.

Malik R, Chhibber S.

J Microbiol Immunol Infect. 2009 Apr;42(2):134-40.

PMID:
19597645
7.
8.
9.

Endogenous IL-10 leads to impaired bacterial clearance and reduced survival in a murine model of chronic peritonitis.

Lenz AM, Franklin GA, Fairweather M, McClintock ML, Jala VR, Peyton JC, Gardner SA, Cheadle WG.

Cytokine. 2007 Dec;40(3):207-15. Epub 2007 Nov 28.

PMID:
18053738
10.
11.

Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.

Vinodkumar CS, Kalsurmath S, Neelagund YF.

Indian J Pathol Microbiol. 2008 Jul-Sep;51(3):360-6.

12.

Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent.

Verma V, Harjai K, Chhibber S.

Curr Microbiol. 2009 Sep;59(3):274-81. doi: 10.1007/s00284-009-9430-y. Epub 2009 May 30.

PMID:
19484297
13.

[The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection].

Bogovazova GG, Voroshilova NN, Bondarenko VM.

Zh Mikrobiol Epidemiol Immunobiol. 1991 Apr;(4):5-8. Russian.

PMID:
1882608
14.

A method for generation phage cocktail with great therapeutic potential.

Gu J, Liu X, Li Y, Han W, Lei L, Yang Y, Zhao H, Gao Y, Song J, Lu R, Sun C, Feng X.

PLoS One. 2012;7(3):e31698. doi: 10.1371/journal.pone.0031698. Epub 2012 Mar 1.

15.

Thalidomide treatment modulates macrophage pro-inflammatory function and cytokine levels in Klebsiella pneumoniae B5055 induced pneumonia in BALB/c mice.

Kumar V, Harjai K, Chhibber S.

Int Immunopharmacol. 2010 Jul;10(7):777-83. doi: 10.1016/j.intimp.2010.04.008. Epub 2010 Apr 22.

PMID:
20399910
16.

In vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB/c mice.

Chadha P, Katare OP, Chhibber S.

Microb Pathog. 2016 Aug 4;99:68-77. doi: 10.1016/j.micpath.2016.08.001. [Epub ahead of print]

PMID:
27498362
17.

Effect of interferon-gamma treatment on the course of a burn wound infection.

Hershman MJ, Sonnenfeld G, Logan WA, Pietsch JD, Wellhausen SR, Polk HC Jr.

J Interferon Res. 1988 Jun;8(3):367-73.

PMID:
3137276
18.

Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia.

Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ.

J Immunol. 1995 Jul 15;155(2):722-9.

PMID:
7608550
19.

Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment.

Verma V, Harjai K, Chhibber S.

J Antimicrob Chemother. 2009 Dec;64(6):1212-8. doi: 10.1093/jac/dkp360. Epub 2009 Oct 4.

20.
Items per page

Supplemental Content

Write to the Help Desk